Global Custom Market Research Reports Provider Company

phone

Neurosurgical Products - Medical Devices Pipeline Assessment, 2017

  • Published Date: 01 Aug 2017
  • Number of Pages: 191
  • Category: Healthcare and Medical
  • Country: Global
Neurosurgical Products - Medical Devices Pipeline Assessment, 2017

Summary

GlobalDatas Medical Devices sector report, Neurosurgical Products - Medical Devices Pipeline Assessment, 2017" provides an overview of Neurosurgical Products currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Neurosurgical Products pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalDatas team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Neurosurgical Products under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Neurosurgical Products and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Neurosurgical Products under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the products current stage of development, territory and estimated launch date
Publisher Name : GlobalData
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 10
2 Introduction 11
2.1 Neurosurgical Products Overview 11
3 Products under Development 12
3.1 Neurosurgical Products - Pipeline Products by Stage of Development 12
3.2 Neurosurgical Products - Pipeline Products by Segment 13
3.3 Neurosurgical Products - Pipeline Products by Territory 14
3.4 Neurosurgical Products - Pipeline Products by Regulatory Path 15
3.5 Neurosurgical Products - Pipeline Products by Estimated Approval Date 16
3.6 Neurosurgical Products - Ongoing Clinical Trials 17
4 Neurosurgical Products - Pipeline Products under Development by Companies 18
4.1 Neurosurgical Products Companies - Pipeline Products by Stage of Development 18
4.2 Neurosurgical Products - Pipeline Products by Stage of Development 20
5 Neurosurgical Products Companies and Product Overview 22
5.1 Accurexa Inc Company Overview 22
5.1.1 Accurexa Inc Pipeline Products & Ongoing Clinical Trials Overview 22
5.2 Anaconda BioMed SL Company Overview 23
5.2.1 Anaconda BioMed SL Pipeline Products & Ongoing Clinical Trials Overview 23
5.3 Arkis BioSciences Company Overview 24
5.3.1 Arkis BioSciences Pipeline Products & Ongoing Clinical Trials Overview 24
5.4 Augusta University Company Overview 25
5.4.1 Augusta University Pipeline Products & Ongoing Clinical Trials Overview 25
5.5 Axion BioSystems Inc Company Overview 26
5.5.1 Axion BioSystems Inc Pipeline Products & Ongoing Clinical Trials Overview 26
5.6 BioArctic AB Company Overview 27
5.6.1 BioArctic AB Pipeline Products & Ongoing Clinical Trials Overview 27
5.7 C2C Development, LLC Company Overview 30
5.7.1 C2C Development, LLC Pipeline Products & Ongoing Clinical Trials Overview 30
5.8 Carl Zeiss Meditec AG Company Overview 31
5.8.1 Carl Zeiss Meditec AG Pipeline Products & Ongoing Clinical Trials Overview 31
5.9 Carnegie Mellon University Company Overview 32
5.9.1 Carnegie Mellon University Pipeline Products & Ongoing Clinical Trials Overview 32
5.10 Carthera SAS Company Overview 33
5.10.1 Carthera SAS Pipeline Products & Ongoing Clinical Trials Overview 33
5.11 Cizeta Surgical Company Overview 37
5.11.1 Cizeta Surgical Pipeline Products & Ongoing Clinical Trials Overview 37
5.12 Cornell University Company Overview 38
5.12.1 Cornell University Pipeline Products & Ongoing Clinical Trials Overview 38
5.13 DiversiLabs, LLC Company Overview 39
5.13.1 DiversiLabs, LLC Pipeline Products & Ongoing Clinical Trials Overview 39
5.14 Elekta AB Company Overview 40
5.14.1 Elekta AB Pipeline Products & Ongoing Clinical Trials Overview 40
5.15 Hadassah Medical Center Company Overview 41
5.15.1 Hadassah Medical Center Pipeline Products & Ongoing Clinical Trials Overview 41
5.16 Integra LifeSciences Holdings Corp Company Overview 42
5.16.1 Integra LifeSciences Holdings Corp Pipeline Products & Ongoing Clinical Trials Overview 42
5.17 International HIFU Company Overview 44
5.17.1 International HIFU Pipeline Products & Ongoing Clinical Trials Overview 44
5.18 JetGuide Ltd Company Overview 45
5.18.1 JetGuide Ltd Pipeline Products & Ongoing Clinical Trials Overview 45
5.19 Mayo Clinic US Company Overview 46
5.19.1 Mayo Clinic US Pipeline Products & Ongoing Clinical Trials Overview 46
5.20 Medprin Regenerative Medical Technologies Co Ltd Company Overview 48
5.20.1 Medprin Regenerative Medical Technologies Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 48
5.21 Medtronic plc Company Overview 49
5.21.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 49
5.22 Monteris Medical Inc Company Overview 53
5.22.1 Monteris Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 53
5.23 MRC Systems GmbH Company Overview 56
5.23.1 MRC Systems GmbH Pipeline Products & Ongoing Clinical Trials Overview 56
5.24 MRI Interventions Inc Company Overview 57
5.24.1 MRI Interventions Inc Pipeline Products & Ongoing Clinical Trials Overview 57
5.25 NICO Corporation Company Overview 59
5.25.1 NICO Corporation Pipeline Products & Ongoing Clinical Trials Overview 59
5.26 Optiscan Imaging Limited Company Overview 60
5.26.1 Optiscan Imaging Limited Pipeline Products & Ongoing Clinical Trials Overview 60
5.27 PediaWorks Inc Company Overview 62
5.27.1 PediaWorks Inc Pipeline Products & Ongoing Clinical Trials Overview 62
5.28 Replication Medical Inc Company Overview 63
5.28.1 Replication Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 63
5.29 Resultados y Calidad del Sistema Sanitario Publico de Andalucia Company Overview 64
5.29.1 Resultados y Calidad del Sistema Sanitario Publico de Andalucia Pipeline Products & Ongoing Clinical Trials Overview 64
5.30 StereoTools SA Company Overview 65
5.30.1 StereoTools SA Pipeline Products & Ongoing Clinical Trials Overview 65
5.31 The Swedish Neuroscience Institute Company Overview 66
5.31.1 The Swedish Neuroscience Institute Pipeline Products & Ongoing Clinical Trials Overview 66
5.32 The University of Utah Company Overview 67
5.32.1 The University of Utah Pipeline Products & Ongoing Clinical Trials Overview 67
5.33 University of California San Francisco Company Overview 69
5.33.1 University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview 69
5.34 University of Colorado Company Overview 70
5.34.1 University of Colorado Pipeline Products & Ongoing Clinical Trials Overview 70
5.35 University of Maryland Baltimore Company Overview 71
5.35.1 University of Maryland Baltimore Pipeline Products & Ongoing Clinical Trials Overview 71
5.36 University of South Florida Company Overview 72
5.36.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 72
5.37 University of Texas Medical Branch at Galveston Company Overview 73
5.37.1 University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview 73
5.38 Vanderbilt University Company Overview 74
5.38.1 Vanderbilt University Pipeline Products & Ongoing Clinical Trials Overview 74
5.39 Xylos Corporation Company Overview 76
5.39.1 Xylos Corporation Pipeline Products & Ongoing Clinical Trials Overview 76
6 Neurosurgical Products- Recent Developments 77
6.1 Jul 27, 2017: High Interest In Early Removal Of Hemorrhagic Stroke Leads To Doubling Number Of Clinical Trial Sites 77
6.2 Jul 27, 2017: Stryker reports second quarter 2017 results 77
6.3 Jul 26, 2017: Integra LifeSciences Reports Second Quarter 2017 Financial Results 78
6.4 Jul 11, 2017: MRI Interventions Announces Record Second Quarter ClearPoint System Procedures, And a 79% Year-Over-Year Revenue Increase 80
6.5 Jul 05, 2017: Penumbra Promotes Daniel Davis to Chief Commercial Officer 80
6.6 Jun 28, 2017: Parkinsons Disease Patients are First to be Treated With Elektas New Leksell Vantage Stereotactic System 81
6.7 Jun 12, 2017: Carevature Medical Announces Pioneering Cervical Spinal Decompressions in the US 82
6.8 May 30, 2017: The German Court has Granted a Preliminary Injunction in Favour of VSY Biotechnology BV and Against Carl Zeiss Meditec 82
6.9 May 25, 2017: Medtronic Reports Fourth Quarter and Fiscal Year 2017 Financial Results 83
6.10 May 23, 2017: Brainlab Chief Financial Officer Joseph Doyle to Retire 86
6.11 May 18, 2017: Renishaw presents implant technology for oral and maxillofacial surgeons 86
6.12 May 17, 2017: Sperling Medical Successfully Treats First Florida Tremor Cases 87
6.13 May 15, 2017: American Shared Hospital Services Reports Higher First Quarter Revenue and Net Income 88
6.14 May 11, 2017: Healthcare Veteran John Fletcher Joins MRI Interventions Board of Directors 89
6.15 May 11, 2017: ZEISS: Significant Growth in Revenue and Earnings 90
6.16 May 10, 2017: Carl Zeiss Meditec accelerates growth in the first six months of 2016/17 91
6.17 May 09, 2017: INSIGHTEC Receives FDA Approval for Exablate Neuro for 1.5T MRI in the Treatment of Essential Tremor 92
6.18 May 09, 2017: Penumbra Reports First Quarter 2017 Financial Results 92
6.19 May 08, 2017: ZEISS Appoints New Fellow 93
6.20 May 02, 2017: Misonix Reports Third Quarter Fiscal Year 2017 Financial Results 94
6.21 May 02, 2017: Brainlab Names New Member of Executive Board 94
6.22 May 01, 2017: Cardinal Health Reports Third-quarter Results for Fiscal Year 2017 95
6.23 Apr 27, 2017: RTI Surgical Announces 2017 First Quarter Results 96
6.24 Apr 27, 2017: MRI Interventions Announces 2017 First Quarter Results 97
6.25 Apr 26, 2017: Integra LifeSciences Reports First Quarter 2017 Financial Results 99
6.26 Apr 25, 2017: The All-new Robotic Visualization System KINEVO 900 from ZEISS Revolutionizes Neurosurgical Visualization 101
6.27 Apr 25, 2017: Stryker reports first quarter 2017 results 102
6.28 Apr 24, 2017: Anaconda Biomed Engages Creganna Medical 103
6.29 Apr 24, 2017: Elekta to Highlight Continued Innovation in Stereotactic Neurosurgery with Leksell Vantage Stereotactic System at AANS 104
6.30 Apr 24, 2017: Precision Intratumoral Delivery of DNX-2401 with the Alcyone MEMS Cannula 105
6.31 Apr 23, 2017: Bard Announces First Quarter Results 106
6.32 Apr 21, 2017: Penumbra Appoints Bridget ORourke to its Board of Directors 106
6.33 Apr 20, 2017: Insightec: First Patient With Benign Brain Tumor has Focused Ultrasound Procedure at Nicklaus Childrens Hospital 107
6.34 Apr 20, 2017: Lysogene Announces Selection of MRI Interventions SmartFlow Cannula for Phase II/III Clinical Study in MPS IIIA 108
6.35 Apr 20, 2017: Arkis BioSciences Expands Clinical Use Of Its New Minimally Invasive Tunneling Guidewire Technology 108
6.36 Apr 18, 2017: Cardinal Health updates fiscal 2017 guidance; Provides early outlook for future fiscal years 109
6.37 Apr 06, 2017: MRI Interventions Announces Record Quarterly Revenue, Record ClearPoint System Procedures in 2017 First Quarter 109
6.38 Apr 04, 2017: Carl Zeiss Meditec Group achieves first half 2016/17 revenue of approximately EUR 588 million 110
6.39 Apr 03, 2017: NICO Announces CE Mark for BrainPath Non-Disruptive Cranial Access Technology 110
6.40 Mar 23, 2017: American Shared Hospital Services Fourth Quarter Net Income Increased 63.2% as Revenue Increased 21.6% 111
6.41 Mar 21, 2017: Dieter Kurz Confirmed as Chairman of the Supervisory Boards at SCHOTT and ZEISS 113
6.42 Mar 20, 2017: Acera Surgical Receives FDA Clearance for Nanofabricated Tissue Scaffold 113
6.43 Mar 16, 2017: Integra LifeSciences Introduces Next Generation CUSA Clarity Ultrasonic Tissue Ablation System 114
6.44 Mar 13, 2017: Misonix Announces Second Quarters of Fiscal 2017 114
6.45 Mar 13, 2017: Misonix Files Forms 10-Q for First and Second Quarters of Fiscal 2017 115
6.46 Mar 10, 2017: IMRIS, Deerfield Imaging appoints Robert C. Korn as Senior Vice President - Global Sales and Marketing 116
6.47 Feb 28, 2017: MRI Interventions Announces 2016 Fourth Quarter and Full Year Results 117
6.48 Feb 28, 2017: Penumbra Reports Fourth Quarter and Full Year 2016 Financial Results 120
6.49 Feb 23, 2017: RTI Surgical Announces 2016 Fourth Quarter, Full Year Results; Initiates Actions to Improve Execution and Return to Profitable Growth 121
6.50 Feb 23, 2017: Avella Specialty Pharmacy recall sterile products produced at Advanced Pharma Houston Location from September 1, 2016 through February 16, 2017 Due to Potential Inaccuracy of Latex Free Label Reference 124
6.51 Feb 23, 2017: Integra LifeSciences Reports Fourth Quarter and Full-Year 2016 Financial Results and Updates 2017 Full-Year Guidance 124
6.52 Feb 23, 2017: Renishaw exhibiting at BioWales 2017 126
6.53 Feb 22, 2017: Top Academic Healthcare Centers Presenting New Surgical Options for Stroke Patients 126
6.54 Feb 21, 2017: Medtronic Reports Third Quarter Financial Results 127
6.55 Feb 20, 2017: ACERA Selected as One of the Best University Startups 2016 by National Council of Entrepreneurial Tech Transfer 130
6.56 Feb 10, 2017: Carl Zeiss Meditec Off to A Solid Start Into Business Year 2016/17 130
6.57 Feb 07, 2017: Cardinal Health Reports Second-quarter Results for Fiscal Year 2017 131
6.58 Feb 06, 2017: Medtronic Awarded U.S. Department of Veterans Affairs National Contracts for Home Telehealth Technologies, with Three Other Vendors 133
6.59 Jan 31, 2017: FDA Grants New Clearance for Brain Surgery Technology 133
6.60 Jan 26, 2017: Bard Announces Fourth Quarter Results 134
6.61 Jan 26, 2017: RTI Surgical Names Camille Farhat Chief Executive Officer 135
6.62 Jan 24, 2017: First Procedure Performed in Medtronic MRI-Guided Laser Ablation Trial to Treat Common Form of Epilepsy 136
6.63 Jan 24, 2017: Stryker reports 2016 results and 2017 outlook 137
6.64 Jan 24, 2017: MRI Interventions Announces Year-End Update, Including 2016 Fourth Quarter and Full Year Revenues 138
6.65 Jan 23, 2017: 7D Surgical Receives FDA 510(K) and Health Canada MDL Clearance for Its Breakthrough Image Guidance System for Spine Surgery 139
6.66 Jan 17, 2017: RTI Surgical Extends Deadline for Nominating Directors to the Board 140
6.67 Jan 10, 2017: NICO Announces First Patient Enrolled in Phase 3 Randomized Controlled Trial on Early Intervention of Hemorrhagic Stroke, Deadliest Form of Stroke 140
6.68 Jan 10, 2017: Stryker provides 2016 preliminary net sales results 141
6.69 Jan 09, 2017: Anaconda BioMed Appoints Mr. Giovanni Leo to its Advisory Board 143
6.70 Jan 09, 2017: Cardinal Health Reaches Settlement With West Virginia 143
7 Appendix 188
7.1 Methodology 188
7.2 About GlobalData 191
7.3 Contact Us 191
7.4 Disclaimer 191

List Of Tables


Table 1: Neurosurgical Products - Pipeline Products by Stage of Development 12
Table 2: Neurosurgical Products - Pipeline Products by Segment 13
Table 3: Neurosurgical Products - Pipeline Products by Territory 14
Table 4: Neurosurgical Products - Pipeline Products by Regulatory Path 15
Table 5: Neurosurgical Products - Pipeline Products by Estimated Approval Date 16
Table 6: Neurosurgical Products - Ongoing Clinical Trials 17
Table 7: Neurosurgical Products Companies - Pipeline Products by Stage of Development 18
Table 8: Neurosurgical Products - Pipeline Products by Stage of Development 20
Table 9: Accurexa Inc Pipeline Products & Ongoing Clinical Trials Overview 22
Table 10: BranchPoint Device - Product Status 22
Table 11: BranchPoint Device - Product Description 22
Table 12: Anaconda BioMed SL Pipeline Products & Ongoing Clinical Trials Overview 23
Table 13: ANCD BRAIN - Product Status 23
Table 14: ANCD BRAIN - Product Description 23
Table 15: Arkis BioSciences Pipeline Products & Ongoing Clinical Trials Overview 24
Table 16: CerebroFlo - Product Status 24
Table 17: CerebroFlo - Product Description 24
Table 18: Augusta University Pipeline Products & Ongoing Clinical Trials Overview 25
Table 19: Surgical Instrument - Neurological Procedures - Product Status 25
Table 20: Surgical Instrument - Neurological Procedures - Product Description 25
Table 21: Axion BioSystems Inc Pipeline Products & Ongoing Clinical Trials Overview 26
Table 22: Microhook Based Nerve Tape Device - Product Status 26
Table 23: Microhook Based Nerve Tape Device - Product Description 26
Table 24: BioArctic AB Pipeline Products & Ongoing Clinical Trials Overview 27
Table 25: Spinal Cord Injury FGF1/Device SC0806 - Product Status 27
Table 26: Spinal Cord Injury FGF1/Device SC0806 - Product Description 27
Table 27: BioArctic AB - Ongoing Clinical Trials Overview 28
Table 28: Spinal Cord Injury FGF1/Device SC0806 - An Open, Randomized, Rehabilitation-controlled Study to Assess Safety, Tolerability, and Efficacy of Heparin Activated Recombinant Fibroblast Growth Factor 1 on a Biodegradable Device in Subjects with Traumatic Spinal Cord Injury 29
Table 29: C2C Development, LLC Pipeline Products & Ongoing Clinical Trials Overview 30
Table 30: NAViTECH Streamlined Device - Product Status 30
Table 31: NAViTECH Streamlined Device - Product Description 30
Table 32: Carl Zeiss Meditec AG Pipeline Products & Ongoing Clinical Trials Overview 31
Table 33: QEVO - Product Status 31
Table 34: QEVO - Product Description 31
Table 35: Carnegie Mellon University Pipeline Products & Ongoing Clinical Trials Overview 32
Table 36: Hydrosurgery System - Product Status 32
Table 37: Hydrosurgery System - Product Description 32
Table 38: Carthera SAS Pipeline Products & Ongoing Clinical Trials Overview 33
Table 39: SonoCloud - Product Status 33
Table 40: SonoCloud - Product Description 33
Table 41: SonoProbe - Product Status 34
Table 42: SonoProbe - Product Description 34
Table 43: Carthera SAS - Ongoing Clinical Trials Overview 35
Table 44: SonoCloud - A Study to Evaluate the Safety of Transient Opening of the Blood-brain Barrier by Low Intensity Pulsed Ultrasound with the SonoCloud Implantable Device in Patients with Recurrent Glioblastoma Before Chemotherapy Administration 36
Table 45: Cizeta Surgical Pipeline Products & Ongoing Clinical Trials Overview 37
Table 46: SKULL GRIP - Product Status 37
Table 47: SKULL GRIP - Product Description 37
Table 48: Cornell University Pipeline Products & Ongoing Clinical Trials Overview 38
Table 49: Tightly-Focused Femtosecond Laser - Product Status 38
Table 50: Tightly-Focused Femtosecond Laser - Product Description 38
Table 51: DiversiLabs, LLC Pipeline Products & Ongoing Clinical Trials Overview 39
Table 52: SAlinac System - Product Status 39
Table 53: SAlinac System - Product Description 39
Table 54: Elekta AB Pipeline Products & Ongoing Clinical Trials Overview 40
Table 55: Leksell Vantage Stereotactic System - Product Status 40
Table 56: Leksell Vantage Stereotactic System - Product Description 40
Table 57: Hadassah Medical Center Pipeline Products & Ongoing Clinical Trials Overview 41
Table 58: MIFUS Device - Product Status 41
Table 59: MIFUS Device - Product Description 41
Table 60: Integra LifeSciences Holdings Corp Pipeline Products & Ongoing Clinical Trials Overview 42
Table 61: Cranial Access Kit - Product Status 42
Table 62: Cranial Access Kit - Product Description 42
Table 63: MAYFIELD Composite - Product Status 43
Table 64: MAYFIELD Composite - Product Description 43
Table 65: Stereotaxy Device - Product Status 43
Table 66: Stereotaxy Device - Product Description 43
Table 67: International HIFU Pipeline Products & Ongoing Clinical Trials Overview 44
Table 68: Focused Ultrasound System - Product Status 44
Table 69: Focused Ultrasound System - Product Description 44
Table 70: JetGuide Ltd Pipeline Products & Ongoing Clinical Trials Overview 45
Table 71: JetGuide System - Neuro - Product Status 45
Table 72: JetGuide System - Neuro - Product Description 45
Table 73: Mayo Clinic US Pipeline Products & Ongoing Clinical Trials Overview 46
Table 74: Minimally Invasive Neurology/Neurosurgery Device - Product Status 46
Table 75: Minimally Invasive Neurology/Neurosurgery Device - Product Description 46
Table 76: Stereotactic-Guided Laser Ablation System - Product Status 47
Table 77: Stereotactic-Guided Laser Ablation System - Product Description 47
Table 78: Medprin Regenerative Medical Technologies Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 48
Table 79: Recranio - Product Status 48
Table 80: Recranio - Product Description 48
Table 81: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 49
Table 82: Stealth Station S8 - Product Status 49
Table 83: Stealth Station S8 - Product Description 49
Table 84: Visualase System - Epilepsy - Product Status 50
Table 85: Visualase System - Epilepsy - Product Description 50
Table 86: Medtronic plc - Ongoing Clinical Trials Overview 51
Table 87: Visualase System - Epilepsy - Stereotactic Laser Ablation for Temporal Lobe Epilepsy 52
Table 88: Monteris Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 53
Table 89: NeuroBlate System - Medically Refractory Epilepsy - Product Status 53
Table 90: NeuroBlate System - Medically Refractory Epilepsy - Product Description 53
Table 91: Monteris Medical Inc - Ongoing Clinical Trials Overview 54
Table 92: NeuroBlate System - Medically Refractory Epilepsy - Feasibility Study on Laser Interstitial Thermal Therapy Ablation for the Treatment of Medical Refractory Epilepsy: FLARE 55
Table 93: MRC Systems GmbH Pipeline Products & Ongoing Clinical Trials Overview 56
Table 94: Multilas - Product Status 56
Table 95: Multilas - Product Description 56
Table 96: MRI Interventions Inc Pipeline Products & Ongoing Clinical Trials Overview 57
Table 97: ClearPoint Electrode Placement Device - Alzheimers Disease - Product Status 57
Table 98: ClearPoint Electrode Placement Device - Alzheimers Disease - Product Description 58
Table 99: ClearPoint Electrode Placement Device - Severe Depression - Product Status 58
Table 100: ClearPoint Electrode Placement Device - Severe Depression - Product Description 58
Table 101: NICO Corporation Pipeline Products & Ongoing Clinical Trials Overview 59
Table 102: Neurosurgery Device - Glioblastoma Multiforme - Product Status 59
Table 103: Neurosurgery Device - Glioblastoma Multiforme - Product Description 59
Table 104: Optiscan Imaging Limited Pipeline Products & Ongoing Clinical Trials Overview 60
Table 105: Neurosurgical Endomicroscopy System - Product Status 60
Table 106: Neurosurgical Endomicroscopy System - Product Description 61
Table 107: PediaWorks Inc Pipeline Products & Ongoing Clinical Trials Overview 62
Table 108: Neurosurgery Resector - Product Status 62
Table 109: Neurosurgery Resector - Product Description 62
Table 110: Replication Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 63
Table 111: Neural Implant - Product Status 63
Table 112: Neural Implant - Product Description 63
Table 113: Resultados y Calidad del Sistema Sanitario Publico de Andalucia Pipeline Products & Ongoing Clinical Trials Overview 64
Table 114: Craniotomy Suture Passer - Product Status 64
Table 115: Craniotomy Suture Passer - Product Description 64
Table 116: StereoTools SA Pipeline Products & Ongoing Clinical Trials Overview 65
Table 117: StereoPod - Product Status 65
Table 118: StereoPod - Product Description 65
Table 119: The Swedish Neuroscience Institute Pipeline Products & Ongoing Clinical Trials Overview 66
Table 120: MR-guided Focused Ultrasound System - Product Status 66
Table 121: MR-guided Focused Ultrasound System - Product Description 66
Table 122: The University of Utah Pipeline Products & Ongoing Clinical Trials Overview 67
Table 123: Computer-Controlled Surgical Cutting Tool - Product Status 67
Table 124: Computer-Controlled Surgical Cutting Tool - Product Description 67
Table 125: Hollow Artificial Conduit - Product Status 68
Table 126: Hollow Artificial Conduit - Product Description 68
Table 127: University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview 69
Table 128: Stereotactic Insertion Guidance System - Product Status 69
Table 129: Stereotactic Insertion Guidance System - Product Description 69
Table 130: University of Colorado Pipeline Products & Ongoing Clinical Trials Overview 70
Table 131: Denver Surgical Corridor - Product Status 70
Table 132: Denver Surgical Corridor - Product Description 70
Table 133: University of Maryland Baltimore Pipeline Products & Ongoing Clinical Trials Overview 71
Table 134: Minimally Invasive Neurosurgical Intracranial Robot - Product Status 71
Table 135: Minimally Invasive Neurosurgical Intracranial Robot - Product Description 71
Table 136: University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 72
Table 137: Dural Knife With Protective Foot-Plate - Product Status 72
Table 138: Dural Knife With Protective Foot-Plate - Product Description 72
Table 139: University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview 73
Table 140: Endoscope With Stimulating Electrode - Product Status 73
Table 141: Endoscope With Stimulating Electrode - Product Description 73
Table 142: Vanderbilt University Pipeline Products & Ongoing Clinical Trials Overview 74
Table 143: Flat-Cut Bit For Cranial Perforator - Product Status 74
Table 144: Flat-Cut Bit For Cranial Perforator - Product Description 74
Table 145: PosiSeat - Product Status 75
Table 146: PosiSeat - Product Description 75
Table 147: Xylos Corporation Pipeline Products & Ongoing Clinical Trials Overview 76
Table 148: Dura Replacement Device - Product Status 76
Table 149: Dura Replacement Device - Product Description 76
Table 150: Glossary 190

List Of Figures


Figure 1: Neurosurgical Products - Pipeline Products by Stage of Development 12
Figure 2: Neurosurgical Products - Pipeline Products by Segment 13
Figure 3: Neurosurgical Products - Pipeline Products by Territory 14
Figure 4: Neurosurgical Products - Pipeline Products by Regulatory Path 15
Figure 5: Neurosurgical Products - Pipeline Products by Estimated Approval Date 16
Figure 6: Neurosurgical Products - Ongoing Clinical Trials 17

In this report, the EMEA Microsurgery for Neurosurgical Instruments market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of

View Report

In this report, the global Neurosurgical Instruments Package market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022,

View Report

U.S. NeuroSurgical Inc (USN) is a medical service company that offers biotechnology and neurosurgery services. The company assists and facilitates medical device manufacturers in gaining access and entry into the

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports